Published in J Nucl Med on March 01, 1995
Pitfalls in the neuroimaging of glioblastoma in the era of antiangiogenic and immuno/targeted therapy - detecting illusive disease, defining response. Front Neurol (2015) 0.97
Neurotransmitter positron emission tomographic-studies in adults with phenylketonuria, a pilot study. Eur J Pediatr (1996) 0.87
Phenylketonuria: reduced tyrosine brain influx relates to reduced cerebral protein synthesis. Orphanet J Rare Dis (2013) 0.86
The development, past achievements, and future directions of brain PET. J Cereb Blood Flow Metab (2012) 0.84
Synthesis, uptake mechanism characterization and biological evaluation of (18)F labeled fluoroalkyl phenylalanine analogs as potential PET imaging agents. Nucl Med Biol (2011) 0.81
Phenylketonuria: brain phenylalanine concentrations relate inversely to cerebral protein synthesis. J Cereb Blood Flow Metab (2014) 0.79
Positron emission tomography (PET): expanding the horizons of oncology drug development. Invest New Drugs (2003) 0.76
Preoperative staging of non-small-cell lung cancer with positron-emission tomography. N Engl J Med (2000) 6.34
No difference in cardiac event-free survival between positron emission tomography-guided and single-photon emission computed tomography-guided patient management: a prospective, randomized comparison of patients with suspicion of jeopardized myocardium. J Am Coll Cardiol (2001) 2.31
Mechanisms of angina pectoris in syndrome X assessed by myocardial perfusion dynamics and heart rate variability. Eur Heart J (1995) 2.21
Radiolabeled amino acids: basic aspects and clinical applications in oncology. J Nucl Med (2001) 2.18
Systematic review of the staging performance of 18F-fluorodeoxyglucose positron emission tomography in esophageal cancer. J Clin Oncol (2004) 1.92
Disease progression continues in patients with advanced Parkinson's disease and effective subthalamic nucleus stimulation. J Neurol Neurosurg Psychiatry (2005) 1.69
The value of FDG-PET in the detection, grading and response to therapy of soft tissue and bone sarcomas; a systematic review and meta-analysis. Cancer Treat Rev (2004) 1.60
Oesophageal endoscopic ultrasound with fine needle aspiration improves and simplifies the staging of lung cancer. Thorax (2004) 1.47
Cerebral perfusion and metabolism in resuscitated patients with severe post-hypoxic encephalopathy. J Neurol Sci (2003) 1.44
Imaging of soft-tissue tumors using L-3-[iodine-123]iodo-alpha-methyl-tyrosine single photon emission computed tomography: comparison with proliferative and mitotic activity, cellularity, and vascularity. Clin Cancer Res (2000) 1.42
The blood-brain barrier and oncology: new insights into function and modulation. Cancer Treat Rev (2000) 1.37
11C-choline positron emission tomography for the evaluation after treatment of localized prostate cancer. Eur Urol (2003) 1.34
Specific MR imaging of human lymphocytes by monoclonal antibody-guided dextran-magnetite particles. Magn Reson Med (1992) 1.33
Effect of spinal cord stimulation on myocardial blood flow assessed by positron emission tomography in patients with refractory angina pectoris. Am J Cardiol (1996) 1.33
Detection of lymph node metastases of squamous-cell cancer of the head and neck with FDG-PET and MRI. J Nucl Med (1995) 1.30
Complete in vivo reversal of P-glycoprotein pump function in the blood-brain barrier visualized with positron emission tomography. Br J Pharmacol (1998) 1.28
Detection of unknown occult primary tumors using positron emission tomography. Cancer (1998) 1.18
Arachnoid cysts of the sylvian fissure. Evidence of fluid secretion. J Neurosurg (1984) 1.16
The distribution of drug-efflux pumps, P-gp, BCRP, MRP1 and MRP2, in the normal blood-testis barrier and in primary testicular tumours. Eur J Cancer (2004) 1.14
Selective MR imaging of labeled human peripheral blood mononuclear cells by liposome mediated incorporation of dextran-magnetite particles. Magn Reson Med (1993) 1.11
Fluorine-18-fluorodeoxyglucose PET imaging of soft-tissue sarcoma. J Nucl Med (1996) 1.11
Analysis of proliferation and apoptosis in brain gliomas: prognostic and clinical value. J Neurooncol (1999) 1.10
Experimental cerebral ischemia in Mongolian gerbils III. Behaviour of the blood-brain barrier. Acta Neuropathol (1976) 1.04
Sentence comprehension and word repetition: a positron emission tomography investigation. Psychophysiology (1999) 1.03
Quantitative myocardial mapping of perfusion and metabolism using parametric polar map displays in cardiac PET. J Nucl Med (1995) 1.03
Comparison of L-[1-11C]methionine and L-methyl-[11C]methionine for measuring in vivo protein synthesis rates with PET. J Nucl Med (1988) 1.02
Visualization of prostate cancer with 11C-choline positron emission tomography. Eur Urol (2002) 1.02
An improved method for the cyclotron production of 13N-labelled ammonia. Int J Appl Radiat Isot (1975) 1.01
Composition of isolated edema fluid in cold-induced brain edema. J Neurosurg (1979) 1.01
Positron emission tomography for staging of oesophageal and gastroesophageal malignancy. Br J Cancer (1998) 1.01
Influence of P-glycoprotein on brain uptake of [18F]MPPF in rats. Eur J Pharmacol (2000) 0.99
Nuclear magnetic resonance relaxation in experimental brain edema: effects of water concentration, protein concentration, and temperature. Magn Reson Med (1988) 0.99
The spreading of cerebral edema from a cold injury in cats. Psychiatr Neurol Neurochir (1968) 0.96
A new in vivo method to study P-glycoprotein transport in tumors and the blood-brain barrier. Cancer Res (1999) 0.96
Visualization of multidrug resistance in vivo. Eur J Nucl Med (1999) 0.96
Striatal dopamine D2 receptors, metabolism, and volume in preclinical Huntington disease. Neurology (2005) 0.95
First-line erlotinib and bevacizumab in patients with locally advanced and/or metastatic non-small-cell lung cancer: a phase II study including molecular imaging. Ann Oncol (2010) 0.95
99mTc-sestamibi is a substrate for P-glycoprotein and the multidrug resistance-associated protein. Br J Cancer (1998) 0.94
Blood-brain barrier P-glycoprotein function is not impaired in early Parkinson's disease. Parkinsonism Relat Disord (2008) 0.93
The pathogenesis of cysts accompanying intra-axial primary and metastatic tumors of the central nervous system. J Neurooncol (1998) 0.93
Changes of relaxation times T1 and T2 in rat tissues after biopsy and fixation. Magn Reson Imaging (1985) 0.93
Localizing components of a complex task: sentence processing and working memory. Neuroreport (1998) 0.92
Cystic lesions of the brain. A classification based on pathogenesis, with consideration of histological and radiological features. Eur J Radiol (1993) 0.92
Fluorine-18-fluorodeoxyglucose assessment of glucose metabolism in bone tumors. J Nucl Med (1998) 0.92
Irradiation of rat brain reduces P-glycoprotein expression and function. Br J Cancer (2007) 0.91
Effects of permanent dual chamber pacing on myocardial perfusion in symptomatic hypertrophic cardiomyopathy. Heart (1996) 0.91
The nigrostriatal dopaminergic system in familial early onset parkinsonism with parkin mutations. Neurology (2001) 0.91
The distribution of cerebral activity related to visuomotor coordination indicating perceptual and executional specialization. Brain Res Cogn Brain Res (1999) 0.90
Molecular imaging: what can be used today. Cancer Imaging (2005) 0.90
Relative changes in regional cerebral blood flow during spinal cord stimulation in patients with refractory angina pectoris. Eur J Neurosci (1997) 0.89
Carbon-11 choline or FDG-PET for staging of oesophageal cancer? Eur J Nucl Med (2001) 0.89
Brain activation related to the representations of external space and body scheme in visuomotor control. Neuroimage (2001) 0.89
Neurotransmitter positron emission tomographic-studies in adults with phenylketonuria, a pilot study. Eur J Pediatr (1996) 0.87
Adenosine A(1) receptors in the central nervous system: their functions in health and disease, and possible elucidation by PET imaging. Curr Med Chem (2011) 0.87
In vivo binding of N-n-propylnorapomorphine in the rat brain: regional localization, quantification in striatum and lack of correlation with dopamine metabolism. Eur J Pharmacol (1983) 0.87
Increased amounts of D-enantiomer dependent on alkaline concentration in the synthesis of L-[methyl-11C]methionine. Int J Rad Appl Instrum A (1988) 0.87
The pathogenesis of cerebral gliomatous cysts. Neurosurgery (1992) 0.87
A feasibility study on L-[1-carbon-11]tyrosine and L-[methyl-carbon-11]methionine to assess liver protein synthesis by PET. J Nucl Med (1996) 0.87
Carbon-11-labeled daunorubicin and verapamil for probing P-glycoprotein in tumors with PET. J Nucl Med (1996) 0.87
Synthesis and evaluation of radiolabeled antagonists for imaging of beta-adrenoceptors in the brain with PET. Neurochem Int (2002) 0.86
Unique myoclonic pattern in corticobasal degeneration. Mov Disord (1995) 0.86
Hepatic artery thrombosis after orthotopic liver transplantation--a fatal complication or an asymptomatic event. Transplant Proc (1989) 0.86
Morphology and origin of arachnoid cysts. Scanning and transmission electron microscopy of three cases. Acta Neuropathol (1978) 0.86
Visualisation of serotonin-1A (5-HT1A) receptors in the central nervous system. Eur J Nucl Med (2001) 0.86
Detection of local recurrence of soft-tissue sarcoma with positron emission tomography using [18F]fluorodeoxyglucose. Ann Surg Oncol (1997) 0.85
Brain activity related to serial cognitive performance resembles circuitry of higher order motor control. Exp Brain Res (1996) 0.85
High central D2-dopamine receptor occupancy as assessed with positron emission tomography in medicated but therapy-resistant schizophrenic patients. Biol Psychiatry (1991) 0.85
Cerebral cation shifts in hypoxic-ischemic brain damage are prevented by the sodium channel blocker tetrodotoxin. Exp Neurol (1988) 0.85
Brain activation related to the change between bimanual motor programs. Neuroimage (1999) 0.85
Carbon-11 labeled tracers for in vivo imaging P-glycoprotein function: kinetics, advantages and disadvantages. Curr Top Med Chem (2010) 0.85
Visual feedback about time estimation is related to a right hemisphere activation measured by PET. Exp Brain Res (2000) 0.85
Endogenous versus exogenous protein tracer passage in blood-brain barrier damage. Adv Neurol (1980) 0.85
Detection of unknown primary head and neck tumors by positron emission tomography. Int J Oral Maxillofac Surg (1997) 0.85
Regional cerebral blood flow changes related to affective speech presentation in persistent vegetative state. Clin Neurol Neurosurg (1997) 0.84
[(11)C]FMAU and [(18)F]FHPG as PET tracers for herpes simplex virus thymidine kinase enzyme activity and human cytomegalovirus infections. Nucl Med Biol (2000) 0.84
Fluid secretion in arachnoid cysts as a clue to cerebrospinal fluid absorption at the arachnoid granulation. J Neurosurg (1986) 0.84
On the pathogenesis of brain tumour cysts: a volumetric study of tumour, oedema and cyst. Neuroradiology (2000) 0.84